The efficacy of antivirals, corticosteroids, and mAbs as acute COVID treatments in reducing the incidence of long COVID: a systematic review and meta-analysis
G Sun, K Lin, J Ai, W Zhang - Clinical Microbiology and Infection, 2024 - Elsevier
Background Whether treatment during acute COVID results in protective efficacy against
long COVID incidence remains unclear. Objectives To assess the relationship between …
long COVID incidence remains unclear. Objectives To assess the relationship between …
The efficacy of antivirals, corticosteroids, and monoclonal antibodies as acute COVID-19 treatments in reducing the incidence of long COVID: a systematic review and …
G Sun, K Lin, J Ai, W Zhang - Clinical …, 2024 - clinicalmicrobiologyandinfection …
Background Whether treatment during acute COVID-19 results in protective efficacy against
long COVID incidence remains unclear. Objectives To assess the relationship between …
long COVID incidence remains unclear. Objectives To assess the relationship between …
[HTML][HTML] Chronic lung inflammation and CK14+ basal cell proliferation induce persistent alveolar-bronchiolization in SARS-CoV-2-infected hamsters
C Li, N Xiao, W Song, AHC Lam, F Liu, X Cui, Z Ye… - Ebiomedicine, 2024 - thelancet.com
Background Post-acute sequalae of COVID-19 defines a wide range of ongoing symptoms
and conditions long after SARS-CoV-2 infection including respiratory diseases. The …
and conditions long after SARS-CoV-2 infection including respiratory diseases. The …
Pirfenidone and Nintedanib in Pulmonary Fibrosis: Lights and Shadows
M Chianese, G Screm, F Salton, P Confalonieri… - Pharmaceuticals, 2024 - mdpi.com
Pirfenidone and Nintedanib are specific drugs used against idiopathic pulmonary fibrosis
(IPF) that showed efficacy in non-IPF fibrosing interstitial lung diseases (ILD). Both drugs …
(IPF) that showed efficacy in non-IPF fibrosing interstitial lung diseases (ILD). Both drugs …
[HTML][HTML] Computer-aided pulmonary fibrosis detection leveraging an advanced artificial intelligence triage and notification software
Background Improvement in recognition and referral of pulmonary fibrosis (PF) is vital to
improving patient outcomes within interstitial lung disease. We determined the performance …
improving patient outcomes within interstitial lung disease. We determined the performance …
[HTML][HTML] Drug-Induced Pulmonary Fibrosis: National Database Analysis
OI Butranova, EN Terekhina, SK Zyryanov… - Biomedicines, 2024 - mdpi.com
Background/Objectives: Pulmonary fibrosis (PF) results in a progressive decline of lung
function due to scarring. Drugs are among the most common causes of PF. The objective of …
function due to scarring. Drugs are among the most common causes of PF. The objective of …
Beyond the Acute Phase: Long-Term Impact of COVID-19 on Functional Capacity and Prothrombotic Risk—A Pilot Study
Background and Objectives: Assessment of the prothrombotic, proinflammatory, and
functional status of a cohort of COVID-19 patients at least two years after the acute infection …
functional status of a cohort of COVID-19 patients at least two years after the acute infection …
Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection–response to Guangting Zeng and Yuchi Zhou
We greatly appreciate Dr. Zeng and Dr. Zhou for their commentary which mentions that risk
factors for post-COVID pulmonary fibrosis include advanced age, disease severity, length of …
factors for post-COVID pulmonary fibrosis include advanced age, disease severity, length of …
Radiological and spirometric changes in relation to drugs used in post COVID pulmonary fibrosis in a cohort of COVID-19 survivors
M Hamoda, AA El-Maksoud, AM Yousef… - The Egyptian Journal of …, 2024 - Springer
Background It has been proposed that prolonged use of anti-inflammatory and anti-fibrotic
drugs diminish the probability of development of lung fibrosis. Prolonged low-dose …
drugs diminish the probability of development of lung fibrosis. Prolonged low-dose …
Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection
G Zeng, Y Zhou - The Lancet Regional Health–Americas, 2023 - thelancet.com
As the pandemic progresses, the sequelaes of SARS-CoV-2 infection are causing concern
and alarm. Due to the high incidence of respiratory failure and the need for mechanical …
and alarm. Due to the high incidence of respiratory failure and the need for mechanical …